caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1174962146

Ghaith Abu ZeinahM.D.

Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 330101
Hospital
CCN 330270
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
297
Beneficiaries
—
Total drug cost
$3.7M
Distinct drugs
6
Brand share
89.2%
Top prescribed drugs
Peginterferon Alfa-2a92 claims
Ruxolitinib Phosphate74 claims
Ropeginterferon Alfa-2b-Njft47 claims
Hydroxyurea32 claims
Momelotinib Dihydrochloride28 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
211
Unique beneficiaries
—
Total services
486
Distinct HCPCS
5
Medicare payment
$48K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
1
By payment type
Consulting Fee$3K
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity